Skip to content

LivaNova LIVN Operating Income

Operating Income at other companies

Abbott logo
AbbottABT
$1.35B-20.6%
Haemonetics logo
HaemoneticsHAE
$67.4M+14.2%
Medtronic logo
MedtronicMDT
$1.87B+30.4%
Boston Scientific logo
Boston ScientificBSX
$1.1B+19.5%
Stryker logo
StrykerSYK
$936M+11.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$44.16M+7.6%

Segments

By segment

See full
Neuromodulation$44.15M-15.7%
Cardiopulmonary$30.07M+21.8%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's operating income?
LivaNova (LIVN) reported operating income of $41.47M in Q1 2026.
How has LivaNova's operating income changed year-over-year?
LivaNova's operating income decreased by 14.7% year-over-year, from $48.62M to $41.47M.
What is the long-term trend for LivaNova's operating income?
Over 3 years (2021 to 2025), LivaNova's operating income has grown at a 533.6% compound annual growth rate (CAGR), from -$784K to $199.39M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.